Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron

AIMS: To compare the efficacy and safety of intravenous (IV) ferric carboxymaltose (FCM) versus oral iron and other IV iron therapies in patients with iron-deficiency anemia (IDA) resulting from gastrointestinal (GI) disorders. METHODS: A pooled analysis of four prospective, randomized, active-contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lichtenstein, Gary R., Onken, Jane E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182423/
https://www.ncbi.nlm.nih.gov/pubmed/30056562
http://dx.doi.org/10.1007/s10620-018-5204-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182423/
https://www.ncbi.nlm.nih.gov/pubmed/30056562
http://dx.doi.org/10.1007/s10620-018-5204-3

Ejemplares similares